Sofosbuvir/Ledipasvir | m-entrepreneurship.com

Product Name :
Sofosbuvir/Ledipasvir

Search keywords :
Sofosbuvir

drugId :
null

Target Vo:
Hepatitis C virus NS5B RNA-dependent RNA polymerase

Target Vo Short Name :
NS5B

Moa_Name:
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors

First Approval Country :
United States

First Approval Date Filter:
2014

Origin Company_Name :
Gilead Sciences Inc

Active Company_Name :
Ain Shams University

Active Indication_Name:
Hepatitis C, Chronic

In Active Indication_Name:
HIV Infections

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT1 Rabbit mAb Autophagy
Glutamate receptor 1 Rabbit mAb MedChemExpress
RFP Tag Antibody (YA882): RFP Tag Antibody (YA882) is an unconjugated, mouse-derived, anti-RFP Tag (YA882) monoclonal antibody. RFP Tag Antibody (YA882) can be used for: WB expriments in species-independent background without labeling.

Author: Betaine hydrochloride

Related Posts